Navigation Links
Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
Date:2/11/2008

SUNNYVALE, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that Andrew D. Miller will be joining Cepheid as Senior Vice President, Chief Financial Officer on April 14, 2008, and will assume responsibility for worldwide financial operations and investor relations. Mr. Miller will report to John L. Bishop, Chief Executive Officer, and replaces John Sluis, who retired from Cepheid effective December 31, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080129/LATU101LOGO)

Mr. Miller comes to Cepheid from Autodesk where he serves as Vice President and Chief Accounting Officer. In this role, Mr. Miller has led Autodesk's worldwide accounting, compliance, SEC reporting, and Sarbanes-Oxley 404 activities with responsibility for delivering financial services globally for this Nasdaq-listed software entity with more than $1.8B in revenues last year.

Prior to joining Autodesk, Mr. Miller was Senior Vice President and CFO for MarketFirst Software, Inc., a leading provider of enterprise marketing automation software. Other previous experience includes Vice President of Worldwide Finance for Cadence Design Systems, and Vice President of Finance and Corporate Controller for Adaptive Broadband Corporation where he was responsible for worldwide finance, accounting, and treasury functions. He also worked at Silicon Graphics, Inc., serving in a series of key senior finance, administration, and operations roles. Prior to SGI, he held various corporate and divisional finance management roles at Network Equipment Technologies.

Mr. Miller began his career as a CPA with Deloitte and Touche, serving many large technology companies. He graduated Summa Cum Laude from Santa Clara University with a Bachelors of Science in Commerce and holds a CPA from the state of California.

"We are extremely pleased to have Andy as a member of the Cepheid management team. He brings a significant track record of success in building financial teams and in implementing systems in high growth and large business operations. His skill sets are expected to be a strong complement to Cepheid's high growth environment," said John Bishop, Cepheid's Chief Executive Officer.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is an on-demand molecular diagnostics company that develops, manufactures and markets fully-integrated systems for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com for more information.


'/>"/>
SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
9. Codexis Appoints Singapore Laboratories Managing Director
10. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2017)... NC (PRWEB) , ... August 09, 2017 , ... Each ... Almost half never recover well enough to live an independent lifestyle and, even worse, ... , A new discovery by doctors at the University of California Davis Medical Center ...
(Date:8/10/2017)... BELLINGHAM, Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... for optics and photonics, has announced an agreement establishing Kinokuniya Company Ltd. as ... relationship with SPIE as the exclusive sales representative for the SPIE Digital Library ...
(Date:8/8/2017)... ... August 08, 2017 , ... HumanZyme Inc., a ... cells, today announced the launch of HumanKine® Interferon beta (IFN beta) ... of interferons that activate Th1-type innate immune responses against viral and bacterial infection, and ...
(Date:8/8/2017)... ... August 08, 2017 , ... uBiome, the ... pediatric dentist and scientist Dr. Jeremy Horst of UCSF School of Medicine, who, ... out research into the use of the oral microbiome as a non-invasive way ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
Breaking Biology News(10 mins):